Harmony Biosciences Holdings Market capitalization 2024

YEAR	REVENUE (undefined USD)	GROSS MARGIN (%)	NET INCOME (undefined USD)
2029e	1.53	30,20	195.21
2028e	1.83	25,18	321.49
2027e	1.24	37,16	575.2
2026e	1.01	45,62	296.46
2025e	0.86	53,83	225.72
2024e	0.72	63,64	128.93
2023	0.58	79,17	128.85
2022	0.44	80,93	181.5
2021	0.31	81,83	34.6
2020	0.16	82,65	-63.8
2019	0.01	73,33	-187.2
2018	-	-	-70.1

YEAR

REVENUE (undefined USD)

GROSS MARGIN (%)

NET INCOME (undefined USD)

2029e

1.53

30,20

195.21

2028e

1.83

25,18

321.49

2027e

1.24

37,16

575.2

2026e

1.01

45,62

296.46

2025e

0.86

53,83

225.72

2024e

0.72

63,64

128.93

2023

0.58

79,17

128.85

2022

0.44

80,93

181.5

2021

0.31

81,83

34.6

2020

0.16

82,65

-63.8

2019

0.01

73,33

-187.2

2018

-70.1

Harmony Biosciences Holdings Aktienanalyse

What does Harmony Biosciences Holdings do?

Harmony Biosciences Holdings Inc is a US-based company specialized in the development and marketing of innovative therapies and treatments for neurological disorders. The company was founded in 2017 and is headquartered in Plymouth Meeting, Pennsylvania. Harmony Biosciences' business model is based on the development of drugs specifically designed to treat sleep disorders and other neurological diseases. The company is a leader in research and development of new compounds in this field and collaborates closely with leading research institutes and experts in the field of sleep medicine. Harmony Biosciences' products are divided into various categories, including narcolepsy, sleep apnea, and other sleep-related disorders. Some of the most well-known products include Pitolisant and Wakix, which are used to treat narcolepsy and EDS. Pitolisant has been approved by the European Medicines Agency and is the first and only drug approved for the treatment of type 1 narcolepsy. Harmony Biosciences heavily invests in research and development of new technologies and approaches to treat sleep disorders and other neurological diseases. The company maintains a strong network of partnerships and collaborations with leading institutes and experts in the field. The goal is to develop new drugs and therapies that improve the quality of life for patients with sleep disorders and other neurological diseases. In addition to drug development, Harmony Biosciences' employees are actively involved in educating and raising awareness about sleep disorders and their impact on health. The company informs and advises patients and their families about various treatment options and actively works on developing new technologies and approaches to improve the diagnosis and treatment of neurological diseases. Overall, Harmony Biosciences aims to improve the quality of life for millions of patients with sleep disorders and other neurological diseases. The company focuses on strategic and collaborative research and development of new technologies and approaches for treating these conditions. With its team of experts and scientists, Harmony Biosciences upholds high standards in research and follows the strict criteria of the medical device industry to develop innovative therapies and medications that will improve the lives of patients worldwide. Harmony Biosciences Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Harmony Biosciences Holdings's Market Capitalization

Harmony Biosciences Holdings's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Harmony Biosciences Holdings's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Harmony Biosciences Holdings's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Harmony Biosciences Holdings’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Harmony Biosciences Holdings Stock

What is the current Harmony Biosciences Holdings market capitalization?

The current market capitalization of Harmony Biosciences Holdings is 1.82 B USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Harmony Biosciences Holdings.

How has the market capitalization of Harmony Biosciences Holdings developed in recent years?

The market capitalization of Harmony Biosciences Holdings has increased/decreased by -11.71% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Harmony Biosciences Holdings?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Harmony Biosciences Holdings?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Harmony Biosciences Holdings have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Harmony Biosciences Holdings pay?

Over the past 12 months, Harmony Biosciences Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Harmony Biosciences Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Harmony Biosciences Holdings?

The current dividend yield of Harmony Biosciences Holdings is .

When does Harmony Biosciences Holdings pay dividends?

Harmony Biosciences Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Harmony Biosciences Holdings?

Harmony Biosciences Holdings paid dividends every year for the past 0 years.

What is the dividend of Harmony Biosciences Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Harmony Biosciences Holdings located?

Harmony Biosciences Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Harmony Biosciences Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Harmony Biosciences Holdings from 6/22/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/22/2024.

When did Harmony Biosciences Holdings pay the last dividend?

The last dividend was paid out on 6/22/2024.

What was the dividend of Harmony Biosciences Holdings in the year 2023?

In the year 2023, Harmony Biosciences Holdings distributed 0 USD as dividends.

In which currency does Harmony Biosciences Holdings pay out the dividend?

The dividends of Harmony Biosciences Holdings are distributed in USD.